NDC 84938-0003-01: Black Cobra Tattoo NumbingSpray 4% Lidocaine .04 g/mL Liquid, 30 mL Bottle
This is a package of 30 mL of Black Cobra Tattoo NumbingSpray 4% Lidocaine .04 g/mL Liquid from Foshan Sugar Max Cosmetics CO.,Ltd, first listed with the FDA May 2025 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 84938-003-01 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 84938 labeler · 003 product · 01 package
- Package marketed since
- May 26, 2025
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 8493800301 3
- FDA record last changed
- Jul 24, 2026
Other active recalls for Lidocaine (different manufacturers) — 2 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 1869797
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Antiarrhythmic class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
- Lidocaine numbs the area where it's applied or injected. Depending on the product, it's used for nerve pain after shingles, minor pain, itching, burns and insect bites, mouth and t...
- Numbness generally starts within about 20 seconds to 1 minute and lasts roughly 5 to 30 minutes. Some products, such as Hilook Blue Gel Anesthetic, list a 15 to 30 minute wait. The...
- Mild reactions include dizziness, drowsiness, nervousness and a brief burning at a patch site. Call for help if you have ringing in the ears, a metallic taste, confusion, twitching...
- Better not to. The toxic effects of local anesthetics add together, and patch labels say not to use them with other topical pain relievers or more than one patch at a time. Ask me...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Lidocaine — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 84938-0003-01 You're viewing this Main listing | 30 mL in 1 BOTTLE | 2025-05-26 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Walgreens pain relieving 4 g/100g 00363-3038-04 | Walgreens | 113 g | — | — | FDA listed | — |
| Aspercreme with Lidocaine Dry 4 g/100mL 41167-0583-05 | Chattem, | 113 ml | — | — | FDA listed | — |
| Burn Relief 40 mg/g 51316-0501-04 | CVS | 113 g | — | — | FDA listed | — |
| Lansinoh Pain Relieving 4 g/100mL 53997-0001-02 | Lansinoh | 1 bottle | — | — | FDA listed | — |
| Foot and Leg Pain Relief 40 mg/g 56104-0007-01 | Premier | 113 g | — | — | FDA listed | — |
| Bactine Max Dry 4 g/100g 65197-0815-04 | WellSpring | 175 ml | — | — | FDA listed | — |
| Fast Freeze Lidocaine 40 mg/mL 66902-0225-04 | Natural | 118 ml | — | — | FDA listed | — |
| Lidocaine Pain Relief 4 g/100g 69396-0178-04 | Trifecta | 113 g | — | — | FDA listed | — |
| Lidocaine Dry 4 g/100mL 69842-0543-04 | CVS | 113 ml | — | — | FDA listed | — |
| HealthWise Lidocaine Pain Relief 4 g/100mL 71101-0068-01 | Veridian | 113 ml | — | — | FDA listed | — |
| HealthWise Maximum Pain Relief 4 g/100mL 71101-0078-01 | Veridian | 113 ml | — | — | FDA listed | — |
| DCH Pain Relief 4 g/100g 72839-0226-04 | Derma | 113 g | — | — | FDA listed | — |
| Black Cobra Tattoo NumbingSpray 4% Lidocaine .04 g/mLthis 84938-0003-01 | Foshan | 30 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Lidocaine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
-
UNII 3XUS85K0RA
Butylene glycol is a clear liquid derived from petroleum or plants that acts as a humectant, solvent, and preservative booster in medicines. It helps keep formulations stable, dissolve active ingredients, and maintain moisture in topical products.
-
UNII 147D247K3P
Ethylhexylglycerin is a synthetic preservative used to prevent bacteria and mold from growing in medicines and personal care products. It helps keep the product safe and stable throughout its shelf life.
-
UNII 6K23F1TT52
Kojic acid is a naturally derived compound used as a preservative and antioxidant in medicines. It helps prevent spoilage and maintain product stability during storage.
-
UNII HIE492ZZ3T
Phenoxyethanol is a synthetic preservative and antimicrobial agent used to prevent bacterial and fungal growth in medicines and cosmetic products, extending shelf life and maintaining product safety.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII YSE9PPT4TH
Hyaluronate sodium is a natural carbohydrate that holds moisture. It's used in medicines as a lubricant, thickener, and moisture-retaining agent to improve texture and delivery of the active ingredient.
-
UNII 55X04QC32I
A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
-
UNII 1Q73Q2JULR
Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
9 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Foshan Sugar Max Cosmetics CO.,Ltd labeler code 84938
- EYE DROPS Carboxymethylcellulose sodium .25 g/100mL Liquid NDC 84938-001-01
- Black Cobra Tattoo Numbing Cream 4% Lidocaine .04 g/g Cream NDC 84938-002-01
- ANTIBACTERIAL FEMININE WIPE Silver Nitrate .01 g Cloth NDC 84938-004-01
- SUNSCREEN Stick Zinc Oxide 15%, Titanium Dioxide 8%, Homosalate 6% .08 g/g; .06 g/g; .15 g/g Stick NDC 84938-005-01
- SUNSCREEN SPRAY150ml Zinc Oxide 15%, Titanium Dioxide 6%, Homosalate 5%, Octisalate 4% .06 g/mL; .15 g/mL; .05 g/mL; .04 g/mL Liquid NDC 84938-006-01
- Sunscreen Cream Zinc Oxide 12%,Titanium Dioxide 8%, Homosalate 12%, Octisalate4.5%,Phenylbenzimidazole Sulfonic Acid 3.5% .035 g/mL; .12 g/mL; .08 g/mL; .12 g/mL; .045 g/mL Cream NDC 84938-007-01
- Shailee Psoriasis Treatment Salicylic Acid 3 g/100mL Liquid NDC 84938-008-01
- Shailee Tea Tree Body Wash Thyme Oil,melaleuca alternifolia,Oregano Oil,Lavender Oi,Undecylenic Acidl 6 [hp_X]/500mL; 4 [hp_X]/500mL; 6 [hp_X]/500mL; 10 [hp_Q]/500mL; 6 [hp_X]/500mL Liquid NDC 84938-009-01
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Temporarily relieves pain and itching due to: Tattoo procedures, Minor scrapes, Minor cuts, Minor skin irritations, Tattoo Laser Remova
⏱️ Dosage and Administration ▾
Adults and children 12 years and older: Apply a generouslayerto the affected area 15-30 minutes before the procedure.Allow the anesthetic to take effect, For prolonged comfort,reapply as necessary, but do not exceed 3 applications in 24hours. Children under 12 years: Consult a doctor before use.
⚠️ Warnings ▾
For external use only
🧪 Active Ingredient ▾
Lidocaine 4%
🧪 Inactive Ingredients ▾
Aqua Propylene Glycol Sodium Hyaluronate Kojic Acid Sodium Hydroxide Trisodium Citrate 1,3-Butanediol Phenoxyethanol Ethylhexylglycerin
🎯 Purpose ▾
External Analgesic
📄 When Using This Product ▾
Keep out of reach of children. Not foruse on children under 12 years old, consult a doctor beforeuse. Avoid contact with eyes, mouth, or open wounds. Do not apply over large areas of the body.
📄 Stop Use and Ask a Doctor If ▾
Stop use and seek medicaattention if irritation, rash, or an allergic reaction occurs, or ifsymptoms worsen or persist for more than seven days.
📄 Keep Out of Reach of Children ▾
lf swallowed, get medical help or contact Poison Control at 1-800-222-1222.Store at room temperature and do not freeze
📄 Package Label / Principal Display Panel ▾
label2
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |